Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Interest Expenses (2016 - 2025)

Bio-Techne has reported Interest Expenses over the past 12 years, most recently at $2.2 million for Q4 2025.

  • Quarterly results put Interest Expenses at $2.2 million for Q4 2025, up 1.07% from a year ago — trailing twelve months through Dec 2025 was $9.3 million (down 14.28% YoY), and the annual figure for FY2025 was $8.5 million, down 45.93%.
  • Interest Expenses for Q4 2025 was $2.2 million at Bio-Techne, down from $2.9 million in the prior quarter.
  • Over the last five years, Interest Expenses for TECH hit a ceiling of $4.9 million in Q3 2023 and a floor of $1.4 million in Q1 2023.
  • Median Interest Expenses over the past 5 years was $2.6 million (2021), compared with a mean of $2.9 million.
  • Peak annual rise in Interest Expenses hit 192.98% in 2024, while the deepest fall reached 55.53% in 2024.
  • Bio-Techne's Interest Expenses stood at $2.9 million in 2021, then dropped by 18.81% to $2.4 million in 2022, then skyrocketed by 83.74% to $4.3 million in 2023, then crashed by 50.38% to $2.1 million in 2024, then rose by 1.07% to $2.2 million in 2025.
  • The last three reported values for Interest Expenses were $2.2 million (Q4 2025), $2.9 million (Q3 2025), and $2.2 million (Q2 2025) per Business Quant data.